Other

Anti-obesity drugs fatten Novo Nordisk profits

Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.

Radiology & Imaging

Special probes improve ultrasound imaging in obese patients

Ultrasound is used to diagnose many diseases in the abdominal cavity. A new study conducted at the University of Leipzig Medical Center and supported by the Helmholtz Institute for Metabolism, Obesity and Vascular Research ...

Medical research

Tirzepatide weight-loss study shows promising results

After 12 initial weeks of weight loss with intensive lifestyle intervention alone, participants in the SURMOUNT-3 study who were randomly assigned to tirzepatide for 72 weeks achieved a total mean reduction in baseline body ...

page 34 from 40